发明名称 Forhindring og behandling av amyloidogen sykdom
摘要 <p>The invention provides improved agents and methods for treatment of diseases associated with amyloid deposits of A² in the brain of a patient. Such methods entail administering agents that induce a beneficial immunogenic response against the amyloid deposit. The methods are useful for prophylactic and therapeutic treatment of Alzheimer's disease. Preferred agents including N-terminal fragments of A² and antibodies binding to the same.</p>
申请公布号 NO20015773(D0) 申请公布日期 2001.11.27
申请号 NO20010005773 申请日期 2001.11.27
申请人 NEURALAB LTD 发明人 SCHENK, DALE B;BARD, FREDERIQUE;VASQUEZ, NICKI J;YEDNOCK, TED
分类号 G01N33/50;A61K38/00;A61K38/17;A61K38/19;A61K39/00;A61K39/39;A61K39/395;A61K48/00;A61K49/00;A61P25/28;C07K14/47;C07K16/18;C12N15/09;G01N33/15;G01N33/53;G01N33/577;G01N33/68;(IPC1-7):A61K 主分类号 G01N33/50
代理机构 代理人
主权项
地址